BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/14/2018 5:53:04 AM | Browse: 1181 | Download: 2760
 |
Received |
|
2018-05-07 01:01 |
|
Peer-Review Started |
|
2018-05-07 03:20 |
|
First Decision by Editorial Office Director |
|
2018-05-23 04:23 |
|
Return for Revision |
|
2018-05-25 11:10 |
|
Revised |
|
2018-06-16 06:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-06-26 11:31 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-06-27 04:10 |
|
Articles in Press |
|
2018-06-27 04:10 |
|
Edit the Manuscript by Language Editor |
|
2018-07-19 18:30 |
|
Typeset the Manuscript |
|
2018-09-03 08:11 |
|
Publish the Manuscript Online |
|
2018-09-14 05:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yuan-Feng Zeng, Yi-Sheng Xiao, Yong Liu, Xiao-Jiang Luo, Li-Dan Wen, Qian Liu and Ming Chen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81201972 |
| Postdoctoral Science Foundation of China |
2013M531555 |
| Postdoctoral Science Foundation of Jiangxi Province |
2013KY44 |
|
| Corresponding Author |
Yuan-Feng Zeng, PhD, Chief Doctor, Department of Pathology, Jiangxi Provincial People's Hospital, 152 Patriotic Road, Donghu District, Nanchang 330006, Jiangxi Province, China. zyf760928@163.com |
| Key Words |
Formin-like 3; Colorectal carcinoma; Invasion; RhoC/FAK pathway; Actin assembly |
| Core Tip |
Formin-like 3 (FMNL3) belongs to the subfamily of diaphanous-related formins, which govern the actin-dependent processes, including cell motility and invasion. The increased expression of FMNL3 in colorectal car¬cinoma (CRC) was shown to contribute to metastasis and poor prognosis of patients in previous studies, however its regulatory mechanism remains unclear. This work reveals that FMNL3 plays a positive role in CRC cell proliferation, invasion and migration. Moreover, FMNL3 activates the RhoC/FAK signaling pathway, and also regulates RhoC-dependent remodeling of actin-based protrusion, such as filopodia and lamellipodia, to promote CRC cell invasion. FMNL3 can be applied as a promising specific biomarker for CRC progression and metastasis. |
| Publish Date |
2018-09-14 05:53 |
| Citation |
Zeng YF, Xiao YS, Liu Y, Luo XJ, Wen LD, Liu Q, Chen M. Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma. World J Gastroenterol 2018; 24(34): 3884-3897 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i34/3884.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i34.3884 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
